Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
GeneDx Holdings Corp., a leading player in the genomic testing industry, is headquartered in the United States. Founded in 2000, the company has established itself as a pioneer in providing comprehensive genetic testing services, particularly in rare and ultra-rare diseases. With a focus on precision medicine, GeneDx offers a range of core services, including whole exome sequencing and targeted gene panels, which are distinguished by their high accuracy and extensive clinical utility.
Operating primarily in North America, GeneDx has achieved significant milestones, including partnerships with healthcare providers and research institutions to enhance patient care through genetic insights. The company’s commitment to innovation and quality has positioned it as a trusted resource in the field of genomics, making it a vital contributor to advancing personalised medicine and improving patient outcomes.
-13 vs industry average
GeneDx Holdings Corp.’s score of 23 is lower than 30% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Business Services is among the least carbon-intensive industries
The Business Services industry has reduced its overall emissions by 25% since 2018
No reported emissions data is available for GeneDx Holdings Corp. yet.
GeneDx Holdings Corp., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company.
As of now, GeneDx does not inherit emissions data from any parent or related organisations, meaning all information is self-reported and reflects their current status in climate commitments. Without specific emissions data or reduction initiatives, it is unclear how GeneDx is addressing climate change or its carbon footprint.
In the broader context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. However, GeneDx has yet to publicly commit to such measures.
No climate goals have been disclosed for GeneDx Holdings Corp. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more